How do I kill thee? Let me count the ways: P53 regulates PARP-1 dependent necrosis

BioEssays

Volumn 36, Issue 1, 2014, Pages 46-51

  Elkholi, Rana ^a   Chipuk, Jerry E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Necrosis; P53; PARP 1; ROS

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN P53;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER THERAPY; CELL CYCLE ARREST; CELL DEATH; CELLULAR STRESS RESPONSE; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; NONHUMAN; SENESCENCE;

APOPTOSIS; NECROSIS; P53; PARP-1; ROS;

ANIMALS; DNA DAMAGE; HUMANS; NECROSIS; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84889666311     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201300117     Document Type: Article

References (29)

1. Lane DP, Crawford LV. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261-3.
2. Linzer DI, Levine AJ. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43-52.
3. Linzer DI, Maltzman W, Levine AJ. 1979. The SV40 A gene product is required for the production of a 54, 000MW cellular tumor antigen. Virology 98: 308-18.
4. Wolf D, Rotter V. 1984. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences. Mol Cell Biol 4: 1402-10.
5. Wolf D, Rotter V. 1985. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790-4.
6. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, et al. 1989. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-21.
7. Malkin D, Li FP, Strong LC, Fraumeni JF, Jr, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-8.
8. Li T, Kon N, Jiang L, Tan M, et al. 2012. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149: 1269-83.
9. Montero J, Dutta C, van Bodegom D, Weinstock D, et al. 2013. p53 regulates a non-apoptotic death induced by ROS. Cell Death Differ 20: 1465-74.
10. Muller PA, Vousden KH. 2013. p53 mutations in cancer. Nat Cell Biol 15: 2-8.
11. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, et al. 2010. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10: 293-301.
12. Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132: 27-42.
13. Crighton D, Wilkinson S, O'Prey J, Syed N, et al. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-34.
14. Feng Z, Zhang H, Levine AJ, Jin S. 2005. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102: 8204-9.
15. Amaravadi RK, Yu D, Lum JJ, Bui T, et al. 2007. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117: 326-36.
16. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, et al. 2008. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10: 676-87.
17. Elkholi R, Floros KV, Chipuk JE. 2011. The role of BH3-only proteins in tumor cell development, signaling, and treatment. Genes Cancer 2: 523-37.
18. Chipuk JE, Green DR. 2006. Dissecting p53-dependent apoptosis. Cell Death Differ 13: 994-1002.
19. Zong WX, Thompson CB. 2006. Necrotic death as a cell fate. Genes Dev 20: 1-15.
20. Chatterjee S, Berger SJ, Berger NA. 1999. Poly(ADP-ribose) polymerase: a guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Mol Cell Biochem 193: 23-30.
21. Andrabi SA, Dawson TM, Dawson VL. 2008. Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci 1147: 233-41.
22. Vaziri H, West MD, Allsopp RC, Davison TS, et al. 1997. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 16: 6018-33.
23. Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R. 1998. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85, 000 proteolytic fragment. Cancer Res 58: 5075-8.
24. Mandir AS, Simbulan-Rosenthal CM, Poitras MF, Lumpkin JR, et al. 2002. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. J Neurochem 83: 186-92.
25. Valenzuela MT, Guerrero R, Nunez MI, Ruiz DeAlmodovar JM, et al. 2002. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene 21: 1108-16.
26. Wieler S, Gagne JP, Vaziri H, Poirier GG, et al. 2003. Poly(ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation. J Biol Chem 278: 18914-21.
27. Tu HC, Ren D, Wang GX, Chen DY, et al. 2009. The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage. Proc Natl Acad Sci USA 106: 1093-8.
28. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, et al. 2012. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149: 1536-48.
29. Valente LJ, Gray DH, Michalak EM, Pinon-Hofbauer J, et al. 2013. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Cell Rep 3: 1339-45.